State of the Industry: Molecular Diagnostics in the Clinical Lab Survey

Question Title

* 3. In 2025, what has been the average number of molecular-based tests (non-COVID-19) performed by your lab daily? (Select only one)

0-100

101-200

201-300

301-400

400+

Question Title

* 4. How much has respiratory testing increased at your lab in 2025? (Select only one)

0-25 percent

26-50 percent

51-75 percent

76-100 percent

101+ percent

It has decreased

Question Title

* 5. Has your lab experienced issues with maintaining a supply of testing products due to supply chain issues? (Select only one)

Yes, a lack of testing supplies has impeded our testing capacity at times.

No, we have adequate testing supplies to meet testing demands.

Question Title

* 6. What testing supplies are you having trouble sourcing due to supply chain issues? (Select all that apply)

Blood collection tubes

Blood culture transfer devices

Controls/Reagents

Culture media

PPE

Pipettes/Pipette tips

Swabs/Consumables

Testing kits for SARS-CoV-2

Transport media

Urine testing supplies

Winged blood collection sets

Lab plastic supplies not noted above

None

Other (please specify)

Question Title

* 7. What types of molecular diagnostic tests do you use in your laboratory? (Select all that apply)

Reverse transcriptase quantitative polymerase chain reaction (rRT-qPCR)

Reverse transcription loop-mediated isothermal amplification (RT-LAMP)

Recombinase polymerase amplification (RPA)

CRISPR-based diagnostics

DNA/Genetic testing

Flow cytometry

Liquid biopsy

Mass Spectrometry

Next generation sequencing

Rapid antigen test

Rapid molecular test

None

Other (please specify)

Question Title

* 8. Which clinical areas are driving the most demand for molecular testing in your lab? (Select all that apply)

Infectious disease (non-COVID)

Oncology

Pharmacogenomics

Genetic/hereditary testing

Reproductive health

Transplant medicine

Neurology

Cardiology

Other (please specify)

Question Title

* 9. Does your lab participate in proficiency testing for molecular assays? If yes, through whom? (Select all that apply)

CAP

API

CDC

WSLH Proficiency Testing

My lab does not participate in proficiency testing for molecular assays

Other (please specify)

Question Title

* 10. Which of the following three molecular diagnostic test companies do you use the most? (Select three)

Abbott

Agilent Technologies

Beckman Coulter

bioMérieux

Bio-Rad

Cepheid

DiaSorin

ELITech Group

Euroimmun/Revvity

GenMark

Hardy Diagnostics

Hologic

Illumina

LabCorp

Leica

Meridian Bioscience

Qiagen

Quest

QuidelOrtho

Roche

Seegene

Siemens

Thermo Fisher Scientific

We outsource all molecular testing

Other (please specify)

Question Title

* 11. How do you handle questionable results with molecular tests? (Select only one)

Repeat the test

Repeat the test with different employee/equipment/test

Verify all pre-analytical, analytical, and/or post-analytical steps are performed correctly

Send results to another lab for verification and second test

Other (please specify)

Question Title

* 12. What steps does your lab take to reduce the number of potential false positive test results? (Select top three)

Repeat the test with the same sample and new extractions

Repeat the test with another method and compare results

Verify all pre-analytic, analytic, post-analytic steps are performed correctly

Refer to quality assurance program guidance

Decontaminate work/test area per laboratory procedures

None

Other (please specify)

Question Title

* 13. Have you adopted or are you planning to adopt AI/ML tools for molecular diagnostics? (Select only one)

Yes, already using

Yes, planning to adopt

No, we are not currently using but plan to

No, we are not currently using and have no plans to

Question Title

* 14. If you would like to be contacted to contribute to this article or other future articles, please provide the following:

First Name

Last Name

Title

Company

Phone

State of the Industry: Molecular Diagnostics in the Clinical Lab

Question Title

* 1. What is your title/position within the lab facility? (Select only one)

Question Title

* 2. What type of facility best describes where you work? (Select only one)

Question Title

* 3. In 2025, what has been the average number of molecular-based tests (non-COVID-19) performed by your lab daily? (Select only one)

Question Title

* 4. How much has respiratory testing increased at your lab in 2025? (Select only one)

Question Title

* 5. Has your lab experienced issues with maintaining a supply of testing products due to supply chain issues? (Select only one)

Question Title

* 6. What testing supplies are you having trouble sourcing due to supply chain issues? (Select all that apply)

Question Title

* 7. What types of molecular diagnostic tests do you use in your laboratory? (Select all that apply)

Question Title

* 8. Which clinical areas are driving the most demand for molecular testing in your lab? (Select all that apply)

Question Title

* 9. Does your lab participate in proficiency testing for molecular assays? If yes, through whom? (Select all that apply)

Question Title

* 10. Which of the following three molecular diagnostic test companies do you use the most? (Select three)

Question Title

* 11. How do you handle questionable results with molecular tests? (Select only one)

Question Title

* 12. What steps does your lab take to reduce the number of potential false positive test results? (Select top three)

Question Title

* 13. Have you adopted or are you planning to adopt AI/ML tools for molecular diagnostics? (Select only one)

Question Title

* 14. If you would like to be contacted to contribute to this article or other future articles, please provide the following: